Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults

Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults

Abstract Background By assessing the changes in concentration of soluble receptor activator of nuclear factor κ B ligand (RANKL) and osteoprotegrin (OPG) after initiation of combination antiretroviral therapy (cART) in treatment-naïve HIV-infected patients we aimed to evaluate whether the initial ac...

Full description

Bibliographic Details
Main Authors: Inger Hee Mathiesen, Mohammad Salem, Jan Gerstoft, Julie Christine Gaardbo, Niels Obel, Court Pedersen, Henrik Ullum, Susanne Dam Nielsen, Ann-Brit Eg Hansen
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Infectious Diseases
Subjects:
RANKL
OPG
cART
BMD
HIV infection
Online Access:http://link.springer.com/article/10.1186/s12879-017-2368-y

Internet

http://link.springer.com/article/10.1186/s12879-017-2368-y

Similar Items